Cellular imaging in drug discovery

[1]  H. Kato,et al.  Disease proteomics toward bedside reality , 2005, Journal of Gastroenterology.

[2]  Alan Trounson,et al.  The production and directed differentiation of human embryonic stem cells. , 2006, Endocrine reviews.

[3]  K. Valenzano,et al.  State-Dependent Compound Inhibition of Nav1.2 Sodium Channels Using the FLIPR Vm Dye: On-Target and Off-Target Effects of Diverse Pharmacological Agents , 2006, Journal of biomolecular screening.

[4]  P. Valent,et al.  Detection of molecular targets on the surface of CD34+/CD38− stem cells in various myeloid malignancies , 2006, Leukemia & lymphoma.

[5]  Meijing Wang,et al.  Stem Cell Transplantation as a Therapeutic Approach to Organ Failure1 , 2005 .

[6]  V. Verkhusha,et al.  Photoactivatable fluorescent proteins , 2005, Nature Reviews Molecular Cell Biology.

[7]  Y. Dor,et al.  How to make pancreatic β cells — prospects for cell therapy in diabetes , 2005 .

[8]  T. Bivona,et al.  Analysis of Ras and Rap activation in living cells using fluorescent Ras binding domains. , 2005, Methods.

[9]  Jeff W M Bulte,et al.  Hot spot MRI emerges from the background , 2005, Nature Biotechnology.

[10]  Jaap Goudsmit,et al.  Affinity ranking of antibodies using flow cytometry: application in antibody phage display-based target discovery. , 2005, Journal of immunological methods.

[11]  Oliver Rausch.  Use of high-content analysis for compound screening and target selection. , 2005, IDrugs : the investigational drugs journal.

[12]  A. Sanfridson,et al.  Inflammatory pathway analysis using a high content screening platform. , 2005, Assay and drug development technologies.

[13]  R. Koop.  Combinatorial biomarkers: From early toxicology assays to patient population profiling. , 2005, Drug discovery today.

[14]  R. Maki,et al.  Functional Selectivity of Melanocortin 4 Receptor Peptide and Nonpeptide Agonists: Evidence for Ligand-Specific Conformational States , 2005, Journal of Pharmacology and Experimental Therapeutics.

[15]  E. Butcher.  Can cell systems biology rescue drug discovery? , 2005, Nature Reviews Drug Discovery.

[16]  Igor L. Medintz,et al.  Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.

[17]  M. Sykes,et al.  Treatment of severe autoimmune disease by stem-cell transplantation , 2005, Nature.

[18]  K. Valenzano,et al.  Validation of a Fluorescent Imaging Plate Reader Membrane Potential Assay for High-Throughput Screening of Glycine Transporter Modulators , 2005, Journal of biomolecular screening.

[19]  Tomohiro Sakamoto,et al.  Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. , 2005, Journal of the American College of Cardiology.

[20]  G. Keller,et al.  Embryonic stem cell differentiation: emergence of a new era in biology and medicine. , 2005, Genes & development.

[21]  B. Hyman,et al.  The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel β-Secretase (BACE1) Substrate* , 2005, Journal of Biological Chemistry.

[22]  Keith A Houck,et al.  High-content screening assay for activators of the Wnt/Fzd pathway in primary human cells. , 2005, Assay and drug development technologies.

[23]  C. Wong,et al.  Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB. , 2005, American journal of respiratory cell and molecular biology.

[24]  Steven G Potkin,et al.  A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease , 2005, Nature Medicine.

[25]  K. Sachs,et al.  Causal Protein-Signaling Networks Derived from Multiparameter Single-Cell Data , 2005, Science.

[26]  Daniel Rauh,et al.  An Unbiased Cell Morphology–Based Screen for New, Biologically Active Small Molecules , 2005, PLoS biology.

[27]  Chad E Jones,et al.  Fluorescence imaging microscopy of cellular markers in ischemic vs non-ischemic cardiomyopathy after left ventricular unloading. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[28]  Sean Ekins,et al.  Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity. , 2005, Trends in pharmacological sciences.

[29]  M. Kinjo,et al.  Analysis of cellular functions by multipoint fluorescence correlation spectroscopy. , 2005, Current pharmaceutical biotechnology.

[30]  Timothy J Mitchison,et al.  Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor. , 2005, Chemistry & biology.

[31]  C. Sigman,et al.  New science-based endpoints to accelerate oncology drug development. , 2005, European journal of cancer.

[32]  Ignacio A. Demarco,et al.  Quantitative imaging of protein interactions in the cell nucleus. , 2005, BioTechniques.

[33]  J. Kofron,et al.  An Offline-Addition Format for Identifying GPCR Modulators by Screening 384-Well Mixed Compounds in the FLIPR , 2005, Journal of biomolecular screening.

[34]  Peter Ramm,et al.  Image-based screening: a technology in transition. , 2005, Current opinion in biotechnology.

[35]  S. Møller,et al.  Identification of Akt Pathway Inhibitors Using Redistribution Screening on the FLIPR and the IN Cell 3000 Analyzer , 2005, Journal of biomolecular screening.

[36]  F. Marshall,et al.  In vivo molecular and cellular imaging with quantum dots. , 2005, Current opinion in biotechnology.

[37]  E. Liu.  Expression genomics and drug development: towards predictive pharmacology. , 2005, Briefings in functional genomics & proteomics.

[38]  X. Wu,et al.  Adult neural stem cell therapy: expansion in vitro, tracking in vivo and clinical transplantation. , 2005, Current drug targets.

[39]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[40]  F. Sams-Dodd.  Target-based drug discovery: is something wrong? , 2005, Drug discovery today.

[41]  A. Jones,et al.  Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. , 2005, Advanced drug delivery reviews.

[42]  B Vojnovic,et al.  Advanced microscopy solutions for monitoring the kinetics and dynamics of drug-DNA targeting in living cells. , 2005, Advanced drug delivery reviews.

[43]  F. Gasparri,et al.  Quantification of the Proliferation Index of Human Dermal Fibroblast Cultures with the ArrayScan™ High-Content Screening Reader , 2004, Journal of biomolecular screening.

[44]  HIGH CONTENT SCREENING emerging impor tance of novel reagents/probes and pathway analysis , 2005 .

[45]  M. Fenech.  In vitro micronucleus technique to predict chemosensitivity. , 2005, Methods in molecular medicine.

[46]  V. Verkhusha,et al.  Innovation: Photoactivatable fluorescent proteins. , 2005, Nature reviews. Molecular cell biology.

[47]  Y. Tang.  Cellular therapy with autologous skeletal myoblasts for ischemic heart disease and heart failure. , 2005, Methods in molecular medicine.

[48]  Meijing Wang,et al.  Stem cell transplantation as a therapeutic approach to organ failure. , 2005, The Journal of surgical research.

[49]  H. Fischer.  Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery. , 2005, Biotechnology annual review.

[50]  Hong Wang,et al.  Automated measurement of cell motility and proliferation , 2005, BMC Cell Biology.

[51]  M. Shibazaki,et al.  Blockade by SB203580 of Cyp1a1 Induction by 2,3,7,8‐Tetrachlorodibenzo‐p‐dioxin, and the Possible Mechanism: Possible Involvement of the p38 Mitogen‐Activated Protein Kinase Pathway in Shuttling of Ah Receptor Overexpressed in COS‐7 Cells , 2004, Annals of the New York Academy of Sciences.

[52]  Michael D. Waters,et al.  Toxicogenomics and systems toxicology: aims and prospects , 2004, Nature Reviews Genetics.

[53]  S. Paris,et al.  Metastasis models: the green fluorescent revolution? , 2004, Carcinogenesis.

[54]  J. Frangioni,et al.  In Vivo Tracking of Stem Cells for Clinical Trials in Cardiovascular Disease , 2004, Circulation.

[55]  Gillian R Richards,et al.  Quantitative assays of chemotaxis and chemokinesis for human neural cells. , 2004, Assay and drug development technologies.

[56]  Oleg Lapets,et al.  A quantitative cell-based high-content screening assay for the epidermal growth factor receptor-specific activation of mitogen-activated protein kinase. , 2004, Assay and drug development technologies.

[57]  Lani F. Wu,et al.  Multidimensional Drug Profiling By Automated Microscopy , 2004, Science.

[58]  E. Holland,et al.  Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model , 2004, Nature Medicine.

[59]  Andreas Radbruch,et al.  Cell therapy for autoimmune diseases: does it have a future? , 2004, Annals of the rheumatic diseases.

[60]  Norbert Perrimon,et al.  Parallel Chemical Genetic and Genome-Wide RNAi Screens Identify Cytokinesis Inhibitors and Targets , 2004, PLoS biology.

[61]  Leroy Hood,et al.  The impact of systems approaches on biological problems in drug discovery , 2004, Nature Biotechnology.

[62]  Alan Hubbard,et al.  Flow cytometric detection of intracellular TH1/TH2 cytokines using whole blood: validation of immunologic biomarker for use in epidemiologic studies. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[63]  Tudor I. Oprea,et al.  Flow cytometry for high-throughput, high-content screening. , 2004, Current opinion in chemical biology.

[64]  K. Almholt,et al.  Changes in intracellular cAMP reported by a Redistribution assay using a cAMP-dependent protein kinase-green fluorescent protein chimera. , 2004, Cellular signalling.

[65]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[66]  Jonathan M Irish,et al.  Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells , 2004, Cell.

[67]  J. Mestan,et al.  AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. , 2004, Cancer research.

[68]  Bernd Hertenstein,et al.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.

[69]  S. Møller,et al.  Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 redistribution screen. , 2004, Assay and drug development technologies.

[70]  T. Mitchison,et al.  Synthesis and Phenotypic Screening of a Guanine‐Mimetic Library , 2004, Chembiochem : a European journal of chemical biology.

[71]  H. Stopper,et al.  Genotoxic activity of newly synthesized derivatives of cyano-pyridone in murine cells in vivo and in vitro. , 2004, TSitologiia i genetika.

[72]  F. Bloom,et al.  Cerebral Cortex Advance Access published March 28, 2004 High-throughput Morphometric Analysis of Individual Neurons , 2022 .

[73]  M. Bruchez,et al.  Optical coding of mammalian cells using semiconductor quantum dots. , 2004, Analytical biochemistry.

[74]  Reuven Agami,et al.  A large-scale RNAi screen in human cells identifies new components of the p53 pathway , 2004, Nature.

[75]  A. Agadir,et al.  Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. , 2004, Clinical immunology.

[76]  Jonathan M Irish,et al.  Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. , 2004, Clinical immunology.

[77]  V. Verkhusha,et al.  The molecular properties and applications of Anthozoa fluorescent proteins and chromoproteins , 2004, Nature Biotechnology.

[78]  T. Liu,et al.  Video microscopy of tumor metastasis: using the green fluorescent protein (GFP) gene as a cancer-cell-labeling system , 1999, Clinical & Experimental Metastasis.

[79]  Riley Rj,et al.  Cellular models for ADMET predictions and evaluation of drug-drug interactions. , 2004 .

[80]  J. G. Kenna,et al.  Cellular models for ADMET predictions and evaluation of drug-drug interactions. , 2004, Current opinion in drug discovery & development.

[81]  J. Mcneish.  Embryonic stem cells in drug discovery , 2004, Nature Reviews Drug Discovery.

[82]  B. O’Rourke,et al.  Two-Photon Microscopy of Cells and Tissue , 2004 .

[83]  F. Bettens,et al.  Lymphocyte proliferation, lymphokine production, and lymphocyte receptors in ageing and various clinical conditions , 2004, Springer Seminars in Immunopathology.

[84]  Achim Kirsch,et al.  A Modular, Fully Integrated Ultra-High-Throughput Screening System Based on Confocal Fluorescence Analysis Techniques , 2003, Journal of biomolecular screening.

[85]  A. Dubin,et al.  Fluorescence Imaging of Electrically Stimulated Cells , 2003, Journal of biomolecular screening.

[86]  T. Garyantes,et al.  Identification of Gap Junction Blockers Using Automated Fluorescence Microscopy Imaging , 2003, Journal of biomolecular screening.

[87]  Atsushi Miyawaki,et al.  Lighting up cells: labelling proteins with fluorophores. , 2003, Nature cell biology.

[88]  Peter Wipf,et al.  Cell-active dual specificity phosphatase inhibitors identified by high-content screening. , 2003, Chemistry & biology.

[89]  P. Shepherd,et al.  Human cell systems for drug discovery. , 2003, Current opinion in drug discovery & development.

[90]  R. Hargreaves,et al.  Clinical biomarkers in drug discovery and development , 2003, Nature Reviews Drug Discovery.

[91]  T. Mitchison,et al.  Phenotypic screening of small molecule libraries by high throughput cell imaging. , 2003, Combinatorial chemistry & high throughput screening.

[92]  W. Colburn,et al.  Biomarkers in Drug Discovery and Development: From Target Identification through Drug Marketing , 2003, Journal of clinical pharmacology.

[93]  L. Lesko,et al.  Use of biomarkers from drug discovery through clinical practice: Report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development , 2003, Clinical pharmacology and therapeutics.

[94]  Ammasi Periasamy,et al.  Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations , 2003, The Journal of cell biology.

[95]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[96]  P. Ramm,et al.  Automated Screening of Neurite Outgrowth , 2003, Journal of biomolecular screening.

[97]  M. Weiss,et al.  Matrix Cells from Wharton's Jelly Form Neurons and Glia , 2003, Stem cells.

[98]  Roger Y. Tsien,et al.  Creating new fluorescent probes for cell biology , 2003, Nature Reviews Molecular Cell Biology.

[99]  Christine C. Hudson,et al.  The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptors. , 2002, Assay and drug development technologies.

[100]  B. Swanson.  Delivery of High-Quality Biomarker Assays , 2002, Disease markers.

[101]  M. Roederer,et al.  The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. , 2002, Clinical chemistry.

[102]  K. Asadullah,et al.  Analysis of cytokine expression in dermatology. , 2002, Archives of dermatology.

[103]  Ravi Kapur,et al.  Fluorescence Imaging and Engineered Biosensors , 2002 .

[104]  Shulamit Levenberg,et al.  Endothelial cells derived from human embryonic stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[105]  Ravi Kapur,et al.  Fluorescence imaging and engineered biosensors: functional and activity-based sensing using high content screening. , 2002, Annals of the New York Academy of Sciences.

[106]  Stephen H. Friend,et al.  Toxicogenomics and drug discovery: will new technologies help us produce better drugs? , 2002, Nature Reviews Drug Discovery.

[107]  K. Patel,et al.  Activity of diadenosine polyphosphates at P2Y receptors stably expressed in 1321N1 cells. , 2001, European journal of pharmacology.

[108]  B. Rice,et al.  In vivo imaging of light-emitting probes. , 2001, Journal of biomedical optics.

[109]  M. Obinata.  Possible applications of conditionally immortalized tissue cell lines with differentiation functions. , 2001, Biochemical and biophysical research communications.

[110]  F. Wouters,et al.  Imaging biochemistry inside cells. , 2001, Trends in cell biology.

[111]  L. Lesko,et al.  Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. , 2001, Annual review of pharmacology and toxicology.

[112]  P. Askenase,et al.  Basophil Responses to Chemokines Are Regulated by Both Sequential and Cooperative Receptor Signaling1 , 2000, The Journal of Immunology.

[113]  A Fowler,et al.  A multi-modality assay platform for ultra-high throughput screening. , 2000, Current pharmaceutical biotechnology.

[114]  M. Mattson.  Emerging neuroprotective strategies for Alzheimer's disease: dietary restriction, telomerase activation, and stem cell therapy , 2000, Experimental Gerontology.

[115]  C. Marsden,et al.  Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. , 2000, Brain : a journal of neurology.

[116]  G. Martin,et al.  Characterization of human recombinant α2A‐adrenoceptors expressed in Chinese hamster lung cells using intracellular Ca2+ changes: evidence for cross‐talk between recombinant α2A‐ and native α1‐adrenoceptors , 2000 .

[117]  Melanie Allen,et al.  Deficiency of the Stress Kinase P38α Results in Embryonic Lethality , 2000, The Journal of Experimental Medicine.

[118]  C. Gabel,et al.  Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. , 2000, The Journal of experimental medicine.

[119]  Ramm,et al.  Imaging systems in assay screening. , 1999, Drug discovery today.

[120]  D A Smith,et al.  Pharmacokinetics and metabolism in early drug discovery. , 1999, Current opinion in chemical biology.

[121]  Nolan,et al.  Flow cytometry: a versatile tool for all phases of drug discovery. , 1999, Drug discovery today.

[122]  J. de Vellis,et al.  NT‐3‐mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo , 1998, Journal of neuroscience research.

[123]  F. Gage,et al.  Neurogenesis in the adult human hippocampus , 1998, Nature Medicine.

[124]  K A Giuliano,et al.  Fluorescent-protein biosensors: new tools for drug discovery. , 1998, Trends in biotechnology.

[125]  Y. Miyagi,et al.  Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. , 1997, Cancer research.

[126]  F. Lacombe,et al.  Flow cytometry study of cell cycle, apoptosis and drug resistance in acute leukemia. , 1996, Hematology and cell therapy.

[127]  B. Neagle,et al.  FLIPR: A New Instrument for Accurate, High Throughput Optical Screening , 1996 .

[128]  Peter Ramm,et al.  Advanced image analysis systems in cell, molecular and neurobiology applications , 1994, Journal of Neuroscience Methods.

[129]  M. Kirsch‐Volders,et al.  Report from the working group on the in vivo mammalian bone marrow chromosomal aberration test. , 1994, Mutation research.

[130]  M Fenech,et al.  The cytokinesis-block micronucleus technique and its application to genotoxicity studies in human populations. , 1993, Environmental health perspectives.

[131]  M. Raebel,et al.  Surrogate Markers for Assessing Treatment Response in HIV Disease , 1993, The Annals of pharmacotherapy.

[132]  A. Björklund,et al.  Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) , 1992, The New England journal of medicine.

[133]  H. Spielmann,et al.  Cytotoxicity test using blastocyst-derived euploid embryonal stem cells: a new approach to in vitro teratogenesis screening. , 1991, Reproductive toxicology.

[134]  J. Droz,et al.  Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma. , 1990, Journal of biological response modifiers.